Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BioForce Nanosciences Holdings Inc. (BFNH : OTC)

• Company Description    BioForce Nanosciences Holdings, Inc. develops and commercializes nanotech tools and solutions for the life sciences. BioForce's flagship product, the Nano eNabler molecular printer, gives the Company a platform for development and discovery. BioForce technology is being used in sensor functionalization; patterning and cell adhesion; and printing proteins to guide neural cell growth. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $0.54 Daily Weekly Monthly 20 Day Moving Average: 832 shares Shares Outstanding: 33.52 (millions) Market Capitalization: $18.10 (millions) Beta: -1.31 52 Week High: $1.44 52 Week Low: $0.33 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.29% -1.54% 12 Week -3.19% -18.57% Year To Date 58.13% 48.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2020 GENERAL BOOTH BLVD UNIT 230 - VIRGINIA BEACH,VA 23454 USA ph: 757-306-6090 fax: 757-306-6092 info@bioforcenano.com http://www.bioforceeclipse.com

• General Corporate Information    Officers Merle Ferguson - Chief Executive Officer; Chairman; President; Trea Sasha Shapiro - President Steve Gagnon - Co Chief Executive Officer John LaViolette - Co Chief Executive Officer Richard Kaiser - Chief Financial Officer; Principal Accounting Offi Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 09064C206 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 33.52 Most Recent Split Date: 2.00 (0.20:1) Beta: -1.31 Market Capitalization: $18.10 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -200.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -30,513.47 12/31/24 - -51,524.71 Current Ratio 06/30/25 - - 03/31/25 - 0.05 12/31/24 - 0.00 Quick Ratio 06/30/25 - - 03/31/25 - 0.05 12/31/24 - 0.00 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - -0.01 12/31/24 - -0.07 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©